KAITLYN KOWALCZYK: Open Payments
NPI 1255973236 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$198 in 11 payments from 10 companies in 2025. Trend: 2023 $1,222 · 2024 $1,080 · 2025 $198
Food & beverage: $198
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 2 | $43 |
| Organon LLC | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Exeltis, USA Inc. | 1 | $18 |
| PFIZER INC. | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: ZURZUVAE, NEXPLANON, Auvelity, MOUNJARO, SLYND, TRUMENBA, UBRELVY, Ozempic.
Industry payments across MI — which companies pay providers there.
